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ABSTRACT
Inhibitory neurotransmitters, chiefly nitric oxide and vasoactive intestinal peptide, cause MLC20
dephosphorylation and muscle relaxation via inhibition of myosin light chain (MLC) kinase and
activation of MLC phosphatase. Hydrogen sulfide (H2S) produced as a byproduct by luminal
sulfate-reducing commensal bacteria or as an endogenous signaling molecule synthesized from
L-cysteine via cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS) regulates muscle
contraction. However, the role of H2S in the regulation of MLC phosphatase activity and MLC20
phosphorylation is not known. The aim of the present study was to examine the expression of
CSE and CBS in smooth muscle cells and to elucidate the molecular mechanism of H2S-induced
muscle relaxation. Expression of CSE and CBS was determined by RT-PCR and western blot in
muscle cells. The effect of H2S on CCh-stimulated RhoA/Rho kinase pathway and muscle
contraction was examined using an endogenous activator of CSE (L-cysteine) and an exogenous
H2S donor (NaHS). Isometric contraction in isolated muscle strips and scanning micrometry in
isolated muscle cells was measured. Rho kinase activity was measured by immunokinase assay.
Expression of CSE, but not CBS was detected in smooth muscle cells of stomach and colon from
mouse, rabbit and human. Carbachol-induced contraction in muscle strips and in freshly
dispersed muscle cells was inhibited by L-cysteine and NaHS in a concentration-dependent
manner (1 to 100 mM). Glibenclamide, an inhibitor of KATP channels and a known target of
H2S, had no effect on the inhibition of contraction by H2S. L-cysteine (10 mM) or NaHS (1
mM) inhibited carbachol-induced Rho kinase activity, and the inhibition by L-cysteine was
blocked in cells transfected with CSE-specific siRNA. We conclude that both endogenous and
exogenous H2S induce muscle relaxation, and the mechanism is inhibition of RhoA/Rho kinase
activity and stimulation of MLCP activity leading to MLC20 dephosphorylation.
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A. INTRODUCTION
H2S is a colorless and flammable gas with a molecular weight of 34.08 and a vapor
density (d) of 1.19, heavier than air (d=1.0). Its smell is characteristic of rotten eggs or the
obnoxious odor of a blocked sewer. Its boiling point is -60.3°C, melting point is -82.3°C, and
freezing point is -86°C. H2S is the sulfur analog of water molecule and can be oxidized in a
series of reactions to form sulfur dioxide (SO2), sulfates such as sulfuric acid, and elemental
sulfur.
The important life-supporting role of hydrogen sulfide (H2S) has evolved from bacteria to
plants, invertebrates, vertebrates, and finally to mammals. Over the years, H2S had only been
known for its toxicity and environmental hazard.1 It has caused life destructions and extinctions
on the earth over centuries. H2S was believed to be the root cause for multiple mass extinctions
on earth, with one of the most significant in the end of Permian period.2 Since the first
description of the toxicity of H2S in 1713, most studies about H2S have been devoted to its toxic
effects. H2S may be released either from inorganic sulfur compound or has its bacterial sources.3
Some anaerobic organisms called green sulfur bacteria (Chlorobium) use sulfate dissolved in
ocean water for respiration instead of oxygen, and subsequently produce H2S.2
Plants are the primary producers of organic sulfur compounds and can couple
photosynthesis to the reduction of sulfate, assimilation into cysteine, and further metabolism into
methionine, glutathione, and many other compounds. 4 They can incorporate inorganic sulfate,
which is reduced to sulfide and is then incorporated into cysteine. Anionic sulfate, which is
relatively abundant in the environment, is the primary sulfur source for plants. After being
transported into roots, sulfate may remain in the roots or be distributed to other parts. The
transportation into cells is mediated by plasma membrane-localized hydrogen/sulfate
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cotransporters, driven by the electrochemical gradient established by the plasma membrane
proton ATPase. Certain plants can process sulfate ion from the soil and convert it into plant
protein. Subsequent decomposition of these plant proteins lead to the release of H2S. This
process also involves a wide variety of actinomycetes, fungi, and the bacteria heterotrophy
Proteus vulgaris. Among those life forms that share the H2S-producing ability with bacteria and
plants are invertebrates. Tissue homogenates of Manila clam Tapes philippinarum and the
lugworm Arenicola marina produce significant quantities of H2S gas. 5 The worm Urechis caupo
Fisher also produces H2S.6
Significant levels of H2S were detected in mammalian tissues from human, rat and cow in
the range of 50- 160 mM.7 Animals have a dietary requirement for sulfur amino acids. Cysteine is
the central intermediate component from which most sulfur compounds are synthesized. The
enzymatic mechanisms for endogenous production of H2S in mammals were also known to be
mostly composed of cystathionine-b-synthase (CBS)8
3-mercaptopyruvate sulfurtransferase (MST).14

15
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cystathionine-g-lyase (CSE)11 12 13 and

It was seen that sodium hydrogen sulfide

(NaHS), a donor of H2S, augmented sodium nitroprusside-induced relaxation of guinea pig
ileum. 16 It also reversed the spasmolytic effects of azide and hydroxylamine on rabbit aortic
strips. In vitro studies revealed that NaHS at toxicologically relevant concentrations had complex
effects on electrophysiology properties of neuronal membrane and an array of K+ conductance17.
H2S donor, NaHS, facilitated the induction of hippocampal long-term potentiation (LTP) at
micromolar concentrations.18 This effect is beneficial, away from the conventionally assumed
toxic image of H2S. The expression of CBS mRNA was then confirmed in the hippocampus
using Northern blot. Although it was not known by then whether altering endogenous H2S level
affects the LTP process, H2S was labeled a “neuromodulator” in the brain. The similar approach
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was employed to show H2S was produced in vascular tissues and induced vasorelaxation.19 It
was demonstrated that both the expression and activity of CSE can be upregulated by Nitric
oxide (NO), leading to increased production of H2S from vascular smooth muscle cells
(SMCs).20 Unlike NO that relaxes blood vessel walls by activating guanylyl cyclase to release
cGMP, the specific molecular targets of H2S in vascular SMCs are KATP channels. This is the
first molecule target of H2S identified in the cardiovascular system. By stimulating KATP
channels, H2S causes vasorelaxation within a physiologically relevant concentration range.

A1. Production and metabolism of Hydrogen Sulfide in mammalian cells

H2S is generated in mammalian cells via both enzymatic and nonenzymatic pathways,
although the nonenzymatic pathway only accounts for a small portion of H2S production. Among
enzymes involved in H2S production, CBS and CSE have been extensively studied. Both the
enzymes use pyridoxal 5’-phosphate (vitamin B6) as a cofactor. MST along with cysteine
aminotransferase (CAT) regulates endogenous H2S level in specific types of cells and tissues.
These enzymes are involved in transsulfuration and reverse transsulfuration pathways in
different capacities and utilize specific substrates.
Cystathionine-b -synthase(CBS). In the presence of cysteine, more so in the presence of
homocysteine, CBS catalyzes the production of H2 S. The most well-known reaction catalyzed by
CBS is the condensation of homocysteine and serine: L serine + L-homocysteine=Lcystathionine + H2O. This is the first significant step in the biosynthesis of cysteine from
methionine by reverse transsulfuration. CBS catalyzes the condensation of cysteine with
homocysteine to form cystathionine and H2S.21 Binding of the allosteric activator, S-adenosyl-Lmethionine (AdoMet or SAM), to the COOH domain of CBS causes a conformational change
11

which activates CBS. SAM is a common cosubstrate involved in methyl group transfers,
transmethylation, transsulfuration, and aminopropylation pathways, and is mostly produced in
liver.22 Deletion of the regulatory domain also can constitutively activate CBS. 23 This regulatory
domain is important for maintaining the tetrameric state of the protein. 24 The calmodulin binding
consensus sequence (19 amino acids) has also been identified in CBS at its COOH terminal
domain. After calcium-activated calmodulin binds to this consensus sequence, the catalytic
domain of CBS opens up and the enzyme becomes active.
CBS expression is significant in the brain is the primary enzyme that catalyzes the
production of H2S in the central nervous system. CBS was found to be highly expressed in the
hippocampus and cerebellum when compared with the cerebral cortex and brain stem.25 In other
tissues, such as cardiovascular system, respiratory system, testes, adrenal, and spleen from rats,
mice or humans, CBS expression is rare or absent.26 In the absence of CBS, these tissues will not
be able to catabolize homocysteine via transsulfuration pathway and therefore become
hypersensitive to homocysteine toxicity. 27 Another consequence for this lack of CBS is that these
tissues would rely on extracellular supply of cysteine due to the deficiency in cysteine synthesis.
Mutations of the regulatory domain of CBS may lead to alterations in the constitutive activation
of this enzyme, leading to hereditary diseases such as in homocystinuric patients.28 At least 153
mutations in human CBS gene have been identified in patients with homocystinuria,29
characterized by an accumulation of homocysteine in the serum and urine. Both gain-of-function
polymorphisms and loss-of-function polymorphism have been identified with the CBS gene.
Apart from production by CBS, H2S production in the brain is partly regulated by
testosterone and SAM.30 Male brains contain more H2S than female brains at each age,
suggesting the involvement of testosterone in the regulation of the H2S level. Glucocorticoids
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also stimulate CBS gene expression. 31 CBS expression is also upregulated by epidermal growth
factor (EGF), transforming growth factor-b (TGF-b), cAMP, and dexamethasone in reactive
astrocytes.32
Cystathionine-g-lyase(CSE). Cystathionine-g-lyase has been conventionally abbreviated
as CSE, CGL, or CTH. CSE has been described as a beta-replacing lyase with a strict specificity
for the primary substrate L-cysteine and for several sulfur-containing co-substrates.33

34

Unlike

CBS which is expressed in the central nervous system, CSE is expressed abundantly in
mammalian cardiovascular system and respiratory system. 35 It appears to be the main H2S
producing enzyme in the liver, kidney, uterus, placenta, as well as pancreatic islets.36 Low levels
of CSE are also detectable in the small intestine and stomach of rodents.37 Small amounts of CSE
mRNA have also been detected in the brain. 38 CSE is capable of using L-cysteine as the substrate
to form two gases, H2S and NH3, and pyruvate.39
The levels of H2S in vascular tissues are affected by NO through two different
mechanisms. NO increases CSE activity in vascular tissues. 40 Rat aortic tissue homogenate,
when incubated with a NO donor for 90 min, significantly increased H2S generation in a
concentration-dependent manner. One possibility is that NO increases the activity of cGMPdependent protein kinase (PKG), which in turn stimulates CSE. Alternatively, NO may directly
act on CSE protein. The second mechanism for NO-induced H2S production is the upregulation
of CSE expression. CSE can be upregulated by bacterial endotoxin41 as well as during liver
regeneration.42 CSE is reported to be repressed during a viral infection in humans due to
immunodeficiency. Some studies show that CSE is significantly unregulated in rats during the
lactation period.43 CSE transcription and protein turnover rates are also affected by vitamin B6
availability. 44 Stimulation of endothelial cells with vascular endothelial growth factor (VEGF)
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upregulates CSE and increases H2S release.45 Testosterone is another endogenous CSE
stimulator. It does not change the expression of CSE but stimulates CSE activity. 46
Human deficiency of CSE may lead to a metabolic disorder named cystathioninuria that is
inherited in an autosomal recessive manner. In patients with Cystathionuria, an excess of
cystathionine is reported in the urine. Other diseases related to CSE mutation include
hypercystathioninemia and increase the risk of developing atherosclerosis and bladder cancer.47
MST

and

CAT.

MST (or SseA)

is synonymous with b-mercaptopyruvate

sulfurtransferase. MST has A and B chains. MST is involved in cyanide detoxification as MST
transfers the sulfane sulfur from substrate to cyanide ion, giving nontoxic thiocyanate and
pyruvate. The first crystal structure of MST was derived from Escherichia coli.

48

The cofactor

of MST is zinc. Another enzyme that has been reported to generate H2S in rat liver is CAT.49
CAT, otherwise known as cysteine aminotransferase also uses PLP (pyridoxal 5-phosphate) as
the cofactor. MST and CAT are localized in both cytosol and mitochondria. MST generates H2S
in the presence of CAT and cofactors 2-oxoglutarate and PLP.50 CAT converts cysteine to 3mercaptopyruvate (3-MP). MST then transfers the sulfur from 3-MP to sulfite or other sulfur
acceptors or form elemental sulfur. The direct outcome of the CAT-MST pathway is the
production of sulfane sulfur (or bound sulfur). H2S would be consequently formed either through
reduction of the atomic sulfur or released from thiosulfate or persulfides.
Transsulfuration and reverse transsulfuration are two opposite processes involving the
interconversion between the sulfur-containing amino acids cysteine and methionine. Reverse
transsulfuration occurs in vertebrates and fungi with the final product being cysteine. 51
Transsulfuration is the transformation of cysteine into homocysteine via the intermediate L-
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cystathionine with the final product being methionine. This occurs mainly in bacteria, fungi, and
plants.

A2. Catabolism of Hydrogen Sulfide
A significant amount of exhaled H2S has been measured after intravenous administration of
sodium sulfide. 52 An increased amount of exhaled H2S has also been reported after inhibition of
endogenous NO synthesis. The endogenous polysulfide DADS (diallyl disulfide) increases the
amount of H2S exhaled, as DADS act as H2S donors when they react with biological thiols such
as GSH. H2S is also excreted in the urine primarily as sulfate (either free sulfate or thiosulfate)
and in feces and flatus unchanged as free sulfide.
In the mitochondria, H2S is first oxidized to thiosulfate and then to sulfite and sulfate.53
The formation of thiosulfate is not enzymatic, but thiosulfate conversion to sulfite and/or sulfate
is catalyzed by sulfide-detoxifying enzymes. Rhodanese is a sulfide-detoxifying enzyme.54
Methylation is another catabolic pathway for H2S. While the oxidation of H2S occurs mainly in
mitochondria, methylation mainly takes place in the cytosol.
The methylation of H2S yields methanethiol (CH3SH). H2S has been reported to be
methylated to methanethiol in vitro by the intestinal mucosa of Sprague-Dawley rats. The
enzyme

Thiol-S-Methyltransferase

(TSMT)

methylates

H2S

into

methanethiol

and

dimethylsulfide. TSMT is a ubiquitous enzyme with the highest activity in the colonic and cecal
mucosa,55 but its activity has also been reported in the liver, lung, and kidney. Compared with
sulfide oxidation, sulfide methylation is slow. H2S can also be scavenged by metallo- or
disulfide-containing molecules such as horseradish peroxidise, catalase, and oxidized
glutathione.56
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A3. Physiological effects of Hydrogen Sulphide
H2S has several features in common with the other two well known “gasotransmitters”
(nitric oxide and carbon monoxide) in the biological systems. 57 Like H2S, both nitric oxide (NO)
and Carbon monoxide (CO) are colorless gases and easily penetrate the biological membrane.
NO is a free radical and produces the extremely toxic hydroxyl radical when it combines with
superoxide. CO is a reducing agent like H2S. With these differences and similarities, H2S, NO,
and CO elicit several effects; some of them are opposite, whereas others are quite similar. 58
H2S as a vasorelaxant: NO, the first identified gasotransmitter, relaxes smooth muscle of
various vasculatures. Substances other than NO, including low-molecular-weight S-nitrosothiol
intermediates, also contribute to the relaxation of smooth muscle. 59

60

CO is known to dilate

different vascular tissues, from conduit arteries to resistant arteries.61 H2S-induced vasorelaxation
has been demonstrated in numerous types of blood vessels (such as aorta, portal vein, mesenteric
artery, cerebral arteries, and vas deferens) from different species (such as rats, mice, cows,
guinea pigs, sheep, and humans). H2S relaxes small mesenteric arteries much more potently than
aortic tissues. 62 Although rat aortic and mesenteric artery tissues produce similar levels of H2S,
H2S is nearly sixfold more potent in relaxing rat mesenteric artery beds than relaxing rat aortic
tissues. The higher sensitivity of mesenteric arteries to H2S speaks for the importance of the gas
in regulating peripheral resistance. H2S also functions as a vasodilator in cerebral circulation.
Topical application of H2S to the newborn pigs induces dilation of pial arterioles.63 This
vasorelaxant effect of H2S appears to be mediated by KATP channels as glibenclamide blocks the
H2S effect. KATP channel is the major molecular target of H2S for its vasorelaxant effect and
smooth muscle hyperpolarization. 64
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The vasorelaxant property of this gasotransmitter gives it a role in regulating peripheral
resistance and blood pressure. Reduced endogenous H2S level, especially in blood vessel wall,
would be the cause for development of hypertension. Direct evidence for the role of endogenous
H2S in blood pressure control was demonstrated in CSE knockout mice.65 The knockout mice
manifested age-dependent development of hypertension which was comparable to that of eNOS
KO mice.66 On the other hand, endothelium-dependent vasorelaxation, triggered by the
activation of muscarinic cholinergic receptors on the endothelium, was severely abolished in
CSE KO mice. Therefore, it can be concluded that hypertension in CSE KO mice is caused by
the elimination of CSE expression in vascular tissues, especially in the endothelium.

H2S as a neuromodulator. In mammalian central nervous system (CNS), CBS was
found highly expressed in the hippocampus and the cerebellum. 67 CBS is mainly localized to
astrocytes68 69and microglial cells, confirmed by immunohistological studies.70 The activation of
Ca2+/calmodulin pathway after neuronal excitation activates CBS-based production of H2S. H2S
has multifaceted and important effects in CNS, and can modulate neurotransmission and
neuromodulation. Glutamate is an important excitatory amino acid that functions as a
neurotransmitter. Glutamate in mammalian brain is known for its role in learning and memory,
such as induction of long-term potentiation (LTP) and perception of pain. LTP is a memory
consolidation process, which is ignited by a brief period of high-frequency presynaptic
stimulation (5–100 Hz), and this initial stimulation would enhance the postsynaptic response to
subsequent presynaptic stimulation for many hours/days after the high-frequency tetanus.
Abnormal glutamate metabolism can lead to excitatory neuronal injury. The neurological effects
of glutamate are mediated by N-methyl-D-aspartate (NMDA) receptors71 in both central and
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peripheral nervous systems, with exceptions in the bone and pancreatic islet.71 It has been found
that at physiologically relevant concentrations H2S selectively enhances NMDA receptormediated currents and expedites the induction of hippocampal LTP in rats.72 On the contrary,
high concentration of H2S would damage brain and lead to decreased learning and memory
function. In addition to activating NMDA receptors, H2S also directly increases glutamate
secretion. With high levels of NaHS stimulation, extracellular concentrations of glutamate were
increased from physiological concentrations of 2–5 to 10–15 mM resulting in cell death.67 H2Sinduced cell neuron death was abolished by NMDA blocker MK-801 and glutamate antagonist
DL-2- amino-5-phosphonovaleric acid.
Suppression of oxidative stress is another effect of H2S in the brain. H2S inhibits protein
oxidation, HOCl-induced cytotoxicity, intracellular protein oxidation, and lipid peroxidation. It
also protects brain endothelial cells from methionine-induced oxidative stress.73

H2S and Inflammation. H2S is known to exert both pro-inflammatory74
inflammatory effects.78

79 80 81 82

75 76 77

and anti-

The upregulation of CSE and the consequent increase in H2S

production induced by LPS or pro-inflammatory cytokines can be viewed as a pro-inflammatory
action83 or as an anti-inflammatory reaction as a compensatory protection mechanism. H2S
possess an anti-proliferative effect on T-Lymphocytes and induces apoptotic death of
polymorphonuclear cells. 84 These effects limit the development of inflammation. Injection of rats
with H2S donors, NaHS and Na2S, inhibited leukocyte infiltration and adherence to vascular
endothelium, and edema formation in a hindpaw edema model. 85 Vice versa, inhibitors of H2S
synthesis increased leukocyte adhesion, leukocyte infiltration, and edema formation.86
Neuroinflammation is another prominent case in point for elucidating the role of H2S in
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inflammatory process. The activation of glial cells and release of inflammatory factors within
brain, together with the recruitment of peripheral immune cells, jointly result in
neuroinflammatory damage. This damage will deteriorate or lead to neurodegenerative diseases,
such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).87 NaHS attenuates LPS-induced
production and release of NO and TNF-a. The anti-inflammatory effect of H2S is also
remarkable in its ability to upregulate anti-inflammatory and cytoprotective genes, such as heme
oxygenase (HO). H2S-induced upregulation of HO expression in pulmonary smooth muscle
cells 88 and macrophages89 has been demonstrated, which is believed to be the consequence of
ERK activation.90
Significant experimental evidence shows that H2S acts as a pro-inflammatory factor in
various animal models, including hindpaw edema, 91 acute pancreatitis, 92 LPS-induced
endotoxemia, 93 and cecal ligation and puncture induced sepsis. Studies have shown that
excessive activation of KATP channels occurs in LPS-induced hypotension and hyporeactivity to
vasoconstrictor agents.94 As H2S is an identified endogenous opener of KATP channels, it was
speculated that abnormal synthesis or activity of H2S may play a part in septic or endotoxic
shock. It was seen that tissue H2S formation and plasma H2S concentrations were increased in a
septic shock rat model induced by cecal ligation and puncture.95 NaHS treatment of these
animals significantly aggravated septic inflammatory damages.96 H2S has also been reported to
stimulate the generation of pro-inflammatory cytokines from human monocytes.97
One such mechanism is that H2S stimulates sensory nerve endings, releasing endogenous
tachykinins such as substance P (SP), calcitonin gene-related peptide (CGRP), and neurokinin A,
which causes neurogenic inflammation. A number of factors are involved in determining
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whether H2S is anti-inflammatory or pro-inflammatory. The concentrations and administration
routes for H2S may yield different inflammatory outcomes.

A4. Molecular mechanisms of action of Hydrogen Sulphide
KATP channels. The activation of KATP channels by H2S is among the first identified
molecular mechanisms for H2S. Recently discovered signaling mechanisms for H2S involves
covalent modification of cysteine residues in proteins through S sulfhydration, converting
cysteine -SH groups to hydropersulfide (-SSH groups).98 S sulfhydration can be explained in a
comparative fashion with S-nitrosylation. S nitrosylation occurs between NO molecules and
cysteine residues of the concerned proteins. 99 Striking similarities between S-sulfhydration and
S-nitrosylation are seen as both involve the covalent modification of cysteines and both are
reversible by reducing agents, such as dithiothreitol (DTT).100 The functional outcome of the
protein modification is different. S Sulfhydration usually contributes to the increased activity of
the modified proteins, but S nitrosylation appears to decrease the activity it in most cases. The
latter could be due to the shielding of critical reactive thiol groups of the proteins. Extensive
experiments on vascular tissues strongly suggest that H2S-induced vasorelaxation is mainly
caused by KATP channel openings causing hyperpolarization. This notion is largely based on the
ability of glibenclamide, a KATP channel antagonist, to block the vasorelaxant effects of H2S.101
Electrophysiological study provides direct evidence that exogenous H2S increases macroscopic
or unitary KATP currents, which is blocked by glibenclamide in isolated rat aortic and mesenteric
SMCs. 102 Thus, H2S-induced hyperpolarization of SMC membrane is abolished by
glibenclamide.
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H2S as a Reducing agent. H2S is a strong reducing agent and may easily interact with
other oxidative species. Its group allows the reduction of disulfide bonds and scavenging of
reactive oxygen species and nitrogen species. 103 Direct scavenge of peroxynitrite and the
reduction of its toxicity by H2S has been reported.104 This effect would endow H2S an
antioxidant role to offer cytoprotection.105

A5. Hydrogen Sulphide in the gastrointestinal system
Endogenous H2S level in GI system is made up of two components. The first source is
sulfate-reducing bacteria present in the lumen of the large intestine. The second source is from
mammalian cells in the GI tract. H2S is produced at 0.2–3.4 mM in the GI tract of mice and
humans by the intestinal microbiota, such as the enterobacterial flora, which use endogenous
sulfur-containing compounds including amino acids. Both CSE and CBS are found to be
expressed in the GI tract of rats, mice and in healthy human colon.106

107 108

In rat ileum, CBS

and CSE mRNA were detected.109 The gastric mucosa expresses both CSE and CBS, although
CSE appears to play a major role in H2S generation as PPG inhibits gastric H2S formation.110
The rate of H2S production in rat ileum is comparable with that of rat aortas.111 Lysine acetyl
salicylate injection into mice (intraperitoneally) increases the endogenous production of H2S in
intestine. 112 H2S also participates in the regulation of various GI functions, from motility control
to secretion and inflammation. Similar to its effect on vascular contractility, H2S inhibits the
motility of jejunum and colon in humans, mice, and rats. The precontracted ileum muscles from
rats and guinea pigs are relaxed by NaHS in vitro.113 The spontaneous contraction of the isolated
ileum tissues from rabbits was also inhibited by NaHS. The relaxant effect of NaHS on the
spontaneous contraction of gastric smooth muscle appears to be mediated by the activation of
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KATP channels. The opening of KATP channels and closing of Kv channels by NaHS had also
been directly demonstrated on freshly dispersed gastric antrum myocytes using the whole cell
patch-clamp recording.114 These observations suggest that two different types of ion channels are
responsible for the dual actions of H2S on gastric motility in guinea pigs. Another ion channel
involved in the effect of NaHS on mouse colon is SKCa channels, since apamin at 3 mM
inhibited NaHS-induced inhibition of colon motility.118 It is also known that H2S may also
indirectly affect GI smooth muscle contractility by acting on neurons of the enteric nervous
system. The presence of H2S in the mucosa/submucosa of the colon stimulates primary afferent
nerve fibers, thus increasing chloride secretion in guinea pigs and humans.115

A6. Gastric motility

Contractions of gastric smooth muscle serves two basic functions: ingested food is
crushed, ground and mixed, liquefying it to form what is called chyme. Chyme is forced through
the pyloric canal into the small intestine, a process called gastric emptying. The stomach can be
divided into two regions on the basis of motility pattern: an accordian-like reservoir that applies
constant pressure on the lumen and a highly contractile grinder.

The upper stomach, composed of the fundus and upper body, shows low frequency,
sustained contractions that are responsible for generating a basal pressure within the stomach.
Importantly, these tonic contractions also generate a pressure gradient from the stomach to small
intestine and are thus responsible for gastric emptying. Interestingly, swallowing of food and
consequent gastric distention inhibits contraction of this region of the stomach, allowing it to
balloon out and form a large reservoir without a significant increase in pressure.

22

The lower stomach, composed of the lower body and antrum, develops strong peristaltic
waves of contraction that increase in amplitude as they propagate toward the pylorus. These
powerful contractions constitute a very effective gastric grinder; they occur about 3 times per
minute in humans and 5 to 6 times per minute in dogs. Gastric distention strongly stimulates this
type of contraction, accelerating liquefaction and hence, gastric emptying. The pylorus is
functionally part of this region of the stomach - when the peristaltic contraction reaches the
pylorus, its lumen is effectively obliterated - chyme is thus delivered to the small intestine in
spurts.

Gastric motility is controlled by a very complex set of neural and hormonal signals.
Smooth muscle cells lack the striated banding pattern found in cardiac and skeletal muscle, and
they receive neural innervation from the autonomic nervous system. In addition, the contractile
state of smooth muscle is controlled by hormones, autocrine/paracrine agents, and other local
chemical signals. Smooth muscle cells also develop tonic and phasic contractions in response to
changes in load or length. Regardless of the stimulus, smooth muscle cells use cross-bridge
cycling between actin and myosin to develop force, and calcium ions (Ca2+) serve to initiate
contraction.116 Contraction of smooth muscle is initiated by a Ca2+-mediated change in the thick
filaments, whereas in striated muscle Ca2+ mediates contraction by changes in the thin filaments.
In response to specific stimuli in smooth muscle, the intracellular concentration of Ca2+ increases
and combines with the acidic protein calmodulin. This complex activates MLC kinase to
phosphorylate the light chain of myosin. Cytosolic Ca2+ is increased through Ca2+ release from
intracellular stores (sarcoplasmic reticulum) as well as entry from the extracellular space through
Ca2+ channels (receptor-operated Ca2+ channels).
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In gastrointestinal smooth muscle cells phosphorylation of Ser19 on the 20-kDa regulatory
light chain of myosin II (MLC20) by Ca2+/calmodulin-dependent myosin light-chain (MLC)
kinase is essential for initiation of muscle contraction.117 118 Excitatory neurotransmitters such as
acetylcholine initiate contraction by increasing cytosolic Ca2+, or [Ca2+]i and activation of
Ca2+/calmodulin-dependent MLCK. 119 The initial increase in [Ca2+]i and MLCK activity are
transient. MLC20 phosphorylation and contraction, however, are sustained via inhibition of MLC
phosphatase.120 Inhibition of MLCP is initiated by two RhoA-dependent pathways: one involves
phosphorylation of MYPT1, the regulatory subunit of MLC phosphatase, at Thr696 by Rho
kinase, and the other involves phosphorylation of the endogenous MLC phosphatase inhibitor,
CPI-17, at Thr38 by PKC.121 122

Inhibitory neurotransmitters such as vasoactive intestinal peptide (VIP) and nitric oxide
(NO) induce relaxation through the generation of cAMP and cGMP and activation of cAMPdependent protein kinase (PKA) or cGMP-dependent protein kinase (PKG). 123 124 Inactivation of
specific targets in the signaling pathways mediating contraction upon phosphorylation by cAMPdependent protein kinase (PKA) or cGMP-dependent protein kinase (PKG) results in muscle
relaxation.125 PKA and PKG act on various loci to inhibit i) MLC kinase by inhibiting IP3
generation and IP3-dependent Ca2+ release, and/or stimulating Ca2+ uptake into the sarcoplasmic
stores, and ii) activate MLC phosphatase by phosphorylating RhoA at Ser188 and inhibiting its
ability to activate Rho kinase, phosphorylating MYPT1 at Ser695 and blocking phosphorylation at
the adjacent Thr696 by Rho kinase, and/or phosphorylating telokin (at Ser13), an endogenous
MLC phosphatase stimulator.126
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Recent studies have demonstrated that hydrogen sulphide (H2S), a gaseous transmitter
like NO and carbon monoxide (CO) is involved in the regulation of several physiological
functions including gastrointestinal motility. 127 H2S, in addition to generation by luminal sulfatereducing commensal bacteria in the colon, is synthesized endogenously from L-cysteine via
pyridoxal-5’-phosphate-dependent enzymes, cystathionine-γ-lyase (CSE) and cystathionine-βsynthase

(CBS).

3-mercaptopyruvate

sulfurtransferase

in

combination

with

cysteine

aminotransferase can also synthesize H2S from L-cysteine.128 In the gastrointestinal tract, H2S synthesizing enzymes have been shown to be expressed by enteric neurons, interstitial cells of
Cajal and epithelial cells. 129 Expression of CBS and CSE is tissue specific. Reduction in the
levels of H2S accompanied by hypertension and reduced endothelium-dependent relaxation of
vascular muscle in mouse lacking CSE and downregulation of CSE/L-cysteine pathway in
spontaneously hypertensive rats underscores the importance of endogenous H2S in the regulation
of cardiovascular functions. H2S exerts its function by acting on various targets, but unlike NO
and CO, it does not affect soluble guanylyl cyclase (sGC activity) and cGMP formation.130
Some of the targets include activation of KATP channels, mitogen-activated protein kinase
pathway, capsaicin-sensitive sensory neurons, T-type Ca2+ channels or interaction with NO
synthase system. 131

One of the most studied mechanisms for muscle relaxation by H2S is activation of KATP
channels. H2S increased KATP channels currents in smooth muscle cells of rat aorta and
mesenteric artery. Although, it is well-established that H2S inhibits gastrointestinal motility in
vivo and both agonist- and electrically-induced contractions in vitro, it is not known for certain
the site of H2S biosynthesis and the mechanism of action. In guinea pig ileum and mouse
stomach and colon, the inhibitory effect of H2S was not affected by the KATP channel inhibitor
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glibenclamide, 132 whereas in the isolated segments of human, mouse and rat colon the inhibitory
effect of H2S was dependent on both glibenclamide-sensitive and apamin-sensitive K+
channels.133 The aim of the present study is to determine the effects of endogenous released and
exogenously applied H2S on smooth muscle function and to identify the targets involved in
mediating the effects of H2S using muscle strips and isolated muscle cells from stomach and
colon of rabbit and mouse. The results demonstrate that both endogenous and exogenous H2S
induce muscle relaxation, and the mechanism involves inhibition of Rho kinase activity and
stimulation of MLCP activity leading to MLC20 dephosphorylation.
RATIONALE
The role of H2S in the regulation of gastrointestinal motility in vivo and in innervated
muscle in vitro has been demonstrated. A direct effect of H2S on smooth muscle and the
mechanism of action were never reported. Hence, the aim of the present study was to examine
the expression of H2S synthesizing enzymes in smooth muscle and characterize the mechanism of
action of H2S involved in the regulation of smooth muscle function.

We have tested the

hypothesis that H2S synthesizing enzyme(s) are present on smooth muscle and their activation
results in the inhibition of muscle contraction. A greater understanding of the H2S role in
smooth muscle could lead to advances with important therapeutic potential in the treatment of
gastrointestinal motility disorders.

B. MATERIALS AND METHODS
B1. Reagents
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Antibodies for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE) were
obtained from proteintech (Chicago, IL). [32P]ATP was obtained from NEN Life Sciences
Products (Boston, MA). [125I]cAMP was obtained from PerkinElmer Life Sciences (Boston,
MA); Y27632 (Rho kinase inhibitor); RNAqueousTM kit was obtained from Ambion, Austin,
TX; LipofectamineTM 2000 transfection reagent, SuperScriptTM II Reverse Transcriptase kit
were obtained from Invitrogen, Carlsbad, CA; PCR reagents were obtained from Applied
Biosystems, Roche. CSE SiRNA and Negative siRNA were obtained from Ambion Life
Technologies, Austin, TX. Collagenase CLS type II and soybean trypsin inhibitor for cell
isolation were obtained from Worthington, Freehold, NJ; Western blotting materials and protein
assay kit, Tris-HCl ready gels were obtained from Bio-Rad Laboratories, Hercules, CA;
Dulbecco’s modified eagle’s medium (DMEM) for primary cell culture was obtained from
Fisher Scientific. All other chemicals were obtained from Sigma, St. Louis, MO.
B2. Animals
New Zealand white rabbits (weight: 4-5 lbs) were purchased from RSI Biotechnology,
Clemmons, NC and euthanized by sodium pentobarbital overdose (100 mg/kg), as approved by
the Institutional Animal Care and Use Committee of the Virginia Commonwealth University.
The animals were housed in the animal facility administered by the Division of Animal
Resources, Virginia Commonwealth University. All procedures were conducted in accordance
with the Institutional Animal Care and Use Committee of the Virginia Commonwealth
University.
B3. Preparation of dispersed smooth muscle cells.
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Smooth muscle cells were isolated from the circular muscle layer of rabbit proximal
stomach (fundus) by sequential enzymatic digestion, filtration, and centrifugation, as previously
described.134

135 136

Briefly, smooth muscle strips were incubated for 30 min at 31oC in 15 ml of

medium containing 120 mM NaCl, 4 mM KCl, 2.6 mM KH2PO4, 0.6 mM MgCl2, 25 mM
HEPES, 14 mM glucose, 2.1% (v/v) Eagle’s essential amino acid mixture, 0.1% collagenase
(type II), and 0.1% soybean trypsin inhibitor. Partly digested tissues were washed with 50 ml of
enzyme-free medium and muscle cells allowed to disperse spontaneously. The cells were
harvested by filtration through 500mm Nitex and centrifuged twice at 350g for 10 min to
eliminate cells and organelles. The experiments were done within 2-3 hours of isolation.
B4- Preparation of cultured gastric smooth muscle cells
Dispersed muscle cells isolated from the stomach were resuspended in DMEM containing
penicillin (200 U/ml), streptomycin (200 µg/ml), gentamycin (100 µg/ml), amphotericin B (2.5
µg/ml) and 10% fetal bovine serum (DMEM-10). The muscle cells were plated at a
concentration of 5 X 105 cells/ml and incubated at 37°C in a 10% CO2 incubator. DMEM-10
medium was replaced every three days for 2-3 weeks until confluence was attained. The muscle
cells in confluent primary cultures were trypsinized (0.5 mg trypsin/ml), re-plated at a
concentration of 2.5 X 105 cells/ml and cultured under the same conditions. All experiments
were done on cells in the first passage.
B5. RT-PCR analysis of CBS and CSE.
Specific primers were designed based on homologous sequences in human, rat, and
mouse CBS and CSE. The primers for Rabbit CSE were Forward 5’-ACA TTT CGC CAC GCA
GGC CA-3’ and, Reverse 5’-CTC CCA GAG CCA AAG GCC GC-3’, generating a fragment of
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560 bp. The primers for mouse CSE were Forward 5’- GGG CAT CTG CAG GGA AAG GAA
CG-3’ and Reverse 5’-GCA GAT TGG TCC ACG CCC CT-3’, generating a fragment of 851 bp.
The primers for human CSE were Forward 5’-TGG ATG GGG CTA AGT ACT GTT TGG C-3’
and Reverse 5’-CAG AGC CAA AGG GCG CTG GAA A-3’, generating a fragment of 312 bp.
Cultured gastric muscle cells were treated with RNaqueous reagent (Ambion, Austin, TX)
followed by an extraction with phenol:chloroform:isoamylalcohol (25:24:1). RNA (5 ml) was
used to synthesize cDNA using Superscript II reverse transcriptase (Applied Biosystems, Foster,
CA) with random hexanucleotide primers. Reversibly transcribed cDNA (5 ml) was amplified by
PCR under standard conditions using the HotMaster Taq DNA polymerase kit (Epicentere
Biotechnologies, Madison, WI) in a final volume of 50 ml containing 100 ng of each primer. The
PCR products were separated by electrophoresis in 1.2% agarose gel in the presence of ethidium
bromide, visualized by ultraviolet fluorescence, and recorded by a ChemiImager 4400
Fluorescence system.
B6. Western blot analysis for CBS and CSE.
Freshly dispersed or cultured smooth muscle cells were solubilized in Triton X-100based lysis buffer plus protease and phosphatase inhibitors. After centrifugation of the lysates at
20,000 g for 10 min at 4°C, protein concentrations of the supernatant were determined with the
DC Protein Assay kit from Bio-Rad (Hercules, CA). Proteins (50 µg) were separated by SDSPAGE and transferred to nitrocellulose membranes (Immobilon-FL, Millipore, Billerica, MA).
The blots were incubated for 12 h at 4°C with antibodies (1:1,000) to CBS and CSE and then for
1 h with secondary antibody conjugated with horseradish peroxidase. The protein bands were
visualized by enhanced chemi-luminescence.
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B7. Transfection of CSE siRNA in cultured gastric cells
CSE-targeted 21 nucleotide siRNA duplex was purchased from Ambion (Austin, TX,
USA). Negative control siRNA, a 21 nucleotide RNA duplex with no sequence homology with
all known genes, was also purchased from Ambion. Transfection of siRNA into cultured smooth
muscle cells from rabbit gastric was achieved using the lipofectamine 2000 transfection reagent
from Invitrogen. Briefly, cells were plated overnight to form 80-90% confluent monolayers. CSE
siRNA at 40 nM and the transfection reagent complex were added to cells in serum-free medium
for 24 h. As a control, negative siRNA was used to transfect rabbit gastric cells.
B8. Measurement of adenylyl cyclase activity
Adenylyl cyclase activity was measured by the formation of the second messenger cAMP
in response to the exogenous donor of H2S, NaHS and the endogenous activator of H2S, LCysteine. Radioimmunoassay using radiolabeled [125I] cAMP was performed to measure the
level of cAMP production. Forsoklin, which is an activator of adenylyl cyclase (AC) is used as a
positive control. The levels of cAMP in response to the NaHS and L-Cysteine are compared to
the cAMP levels induced by forsoklin. One milliliter of cell suspension contains approximately 3
x 106 cells/ml. The experiments were performed after the cells were treated with NaHS (1mM)
and L-Cysteine (10mM). Another set of cells were treated with 10µM of forskolin. Following
treatment the reaction was terminated with cold 6% trichloroacetic acid (v/v) and vortexed
vigorously. The mixture was then centrifuged and the supernatant was collected and were
extracted three times with water-saturated diethyl ether to remove the trichloroacetic acid and
then lyophilized and frozen at -20oC. Before radioimmunoassay, the samples were reconstituted
in 500 µl of 50mM sodium acetate (pH 6.2) and acetylated with triethylamine/acetic anhydride
(2:1 v/v) for 30 min. Cyclic AMP was measured in triplicates using 100 µl aliquots and the
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results were analyzed and derived from a standard curve using Prism @ GraphPad program. The
results were expressed as pmol of cAMP/mg protein
B9. Assay for Rho kinase activity.
Rho kinase activity was determined in cell extracts by immunokinase assay as previously
described.137 Freshly dispersed smooth muscle cells from rabbit stomach were treated the
contractile agonist carbachol (0.1 µM) in the presence or absence of different concentrations of
NaHS or L-Cysteine for 10 min and solubilized in lysis buffer containing 50 mM Tris-HCl (pH
7.5), 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40, 150 mM NaCl, 1 mM PMSF, 10
mg /ml aprotinin, 10 mg /ml pepstatin A, and 10 mg /ml leupeptin. Equal amounts of protein

extracts were incubated with Rho kinase-2 antibody plus protein A/G agarose overnight at 4°C.
Immunoprecipitates were washed twice with a phosphorylation buffer containing 10 mM MgCl2
and 40 mM HEPES (pH 7.4) and then incubated for 5 min on ice with myelin basic protein
(MBP) (1 mg/ml) as a substrate for Rho kinase activity. The kinase reaction was initiated by the
addition of 10 mCi of [32P]ATP (3,000 Ci/mmol) and 20 mM ATP, followed by an incubation for
10 min at 37°C. 32P-labeled myelin basic protein was absorbed onto phosphocellulose disks, and
repeated washings with 75 mM phosphoric acid removed unbound [32P]ATP. The extent of
phosphorylation was determined from the radioactivity on phosphocellulose discs by liquid
scintillation.
B10. Measurement of contraction and relaxation in muscle strips.
Circular muscle Strips from the proximal stomach of rabbit were collected and rinsed
immediately in Kreb’s solution containing 118 mM NaCl, 4.8 mM KCl, 1mM MgSO4, 1.15 mM
NaH2PO4, 15 mM NaHCO3, 10.5 mM Glucose and 2.5 mM CaCl2. Muscle strips were cut along
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the circular axis and tied at each end with silk thread and mounted vertically in 5 ml tissue bath
containing oxygenated (95% O2/5%CO2) Kreb’s solution at a pH of 7.4 at 37ºC. The tissues were
mounted between glass rod and an isometric transducers (Grass Technologies) connected to a
computer recording system (Polyview). Preparations were allowed to equilibrate for 1 h at
resting tension (2g) before initiation of experiments and bath buffer solution was changed every
15 minutes during equilibration. To measure NaHS or L-cysteine induced relaxation, the strips
were precontracted with 10 mM CCh, and after obtaining stable sustained contraction different
concentrations of L-cysteine or NaHS were cumulatively added. In a separate study 10 mM
glibenclamide, a KATP channel blocker was added to the organ bath for 15 min before CCh or
NaHS or L-cysteine treatment. At the end of each experiment, the strips were blotted dry and
weighed (tissue wet weight). Contractile activity of muscle strips from stomach was calculated
as maximum force generated in response to CCh and relaxation was calculated as percent
decrease in maximum contraction
B11. Measurement of contraction and relaxation in freshly isolated muscle cells.
Contraction in freshly dispersed gastric smooth muscle cells was determined by scanning
micrometry as previously described (22-24). Freshly isolated muscle cells (0.4 ml) containing
(104/cell ml) from proximal stomach were preincubated with different concentrations of Lcysteine, NaHS and then 10mM CCh was added for 10 min. The reaction was terminated with
1% acrolein. The same experiments were repeated in cells preincubated for 15 min with a KATP
channel inhibitor 10 mM glibenclamide. The resting cell length was determined in control
experiments in which muscle cells were incubated with 100 ml of 0.1% bovine serum albumin in
the absence of CCh. The mean cell length of 50 muscle cells was measured by scanning
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micrometry. Contraction in response to CCh was expressed as decrease in mean cell length from
control cell length and relaxation was measured as percent decrease in contractile response in the
presence of L-cysteine and NaHS.
B12. Statistical Analysis
The results were expressed as means +S.E.M of n experiments and analyzed for statistical
significance using Student t-test for paired and unpaired values. Each experiment was performed
on cells and tissues obtained from different animals. Difference of responses among different
groups were tested and confirmed for significance using Fisher’s protected least significance
difference test. The results were analysed using GraphPad software, San Diego, CA. A
probability of P< 0.05 was considered significance.
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RESULTS
C1. Expression of CSE enzyme in smooth muscle cells from stomach and colon.
To examine the role of endogenous H2S in the regulation of muscle function, expression
of the two main enzymes involved in the synthesis of H2S was determined by RT-PCR and
western blot. mRNA expression was determined in cultured muscle cells to avoid amplification
from cell other than muscle cells. Previous studies have determined the purity of cultured
muscle cells with smooth muscle-specific g-actin and absence of interstitial cells of Cajal and
endothelial cells in the primary cultures after first passage138 Expression of mRNA for CSE, but
not CBS was detected in muscle cells from stomach and colon. A PCR product of the expected
size was obtained with CSE specific primers using RNA isolated from cultured muscle cells
derived from the stomach and colon of rabbit (560 bp), mouse (851 bp) and human (312 bp)
(Fig. 1A). Under similar conditions, there was no detectable PCR product with CBS-specific
primers using RNA from cultured muscle cells of the stomach and colon of rabbit, mouse and
human. However, a PCR product of expected size was obtained using CBS-specific primers
with RNA isolated from mouse STC-1 cells (data not shown).
Western blot analysis using specific antibody to CSE demonstrated the presence of CSE
protein (66 kDa) in lysates derived from muscle cells of the stomach and colon (Fig. 1B). Under
similar conditions, there was no detectable expression of CBS protein with the lysates derived
from dispersed muscle cells of the stomach and colon of rabbit, mouse and human. However,
expression of CBS protein was obtained using CBS-specific antibody with lysates prepared from
mouse STC-1 cells (data not shown). These results suggest that muscle cells selectively express
CSE and this is consistent with the tissue-specific expression of CSE and CBS.139
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C2. Inhibition of contraction by H2S in muscle strips.
We next examined the role of H2S in the regulation of muscle function by isometric
contraction and scanning micrometry. Isometric contraction was measured by organ bath in
muscle strips and by scanning micrometry in freshly dispersed muscle cells. Muscle strips from
the proximal stomach were allowed to equilibrate to a passive tension 2g for 1hr before
experiments were conducted. Sustained peak contraction in response to CCh was defined as tone
above basal. As shown previously140, carbachol (CCh, 10 µM) induced a sustained contraction
of 12 g above basal tension.

Addition of L-cysteine caused inhibition of CCh-induced

contraction (i.e. relaxation) in a concentration-dependent fashion (Fig. 2). Relaxation responses
were 5±3 % at 1 mM L-cysteine (NS), 21±3% at 10 mM L-cysteine (p<0.01), and 55±5 % at
100 mM L-cysteine (p<0.01). Previous studies141 in vascular and visceral muscle have shown
that relaxation in response to H2S was mediated by activation of plasma membrane KATP
channels and hyperpolarization.
glibenclamide.

The notion was examined using KATP channel inhibitor

Incubation of muscle strips with glibenclamide (10μM) did not affect the

relaxation in response to L-cysteine: 18±4% at 1 mM L-cysteine (p<0.01), 28±4% at 10 mM Lcysteiene (p<0.01), and 68±5% at 100 mM L-cysteine (p<0.001) (Fig 2). The results suggest
that relaxation of sustained contraction by L-cysteine was not due to activation of KATP channels.
Addition of H2S donor, NaHS also caused inhibition of CCh-induced contraction in a
concentration-dependent fashion (Fig. 3). Relaxation responses were 52±4 % at 1 mM NaHS
(p<0.001), 97±8% at 10 mM NaHS (p<0.001), and 100±9% at 100 mM NaHS (p<0.001). As in
response to L-cysteine, relaxation in response to NaHS was not affected by incubation of muscle
strips with glibenclamide (Fig. 3): 68±5% at 1 mM NaHS (p<0.001), 97±10% at 10 mM NaHS
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(p<0.001), 96±9% at 100 mM NaHS (p<0.001) (Fig. 3). The results suggest that relaxation of
sustained contraction by H2S was not due to activation of KATP channels.
C3. Inhibition of contraction by H2S in isolated muscle cells.
Relaxation in response to L-cysteine and NaHS in innervated muscle strips could be due
to release of transmitters from the enteric neurons, which in turn, modulate the intrinsic electrical
and mechanical activity of the gastrointestinal smooth muscle.143 To avoid the confounding
effects of neural activation by H2S, we examined the effect of L-cysteine and NaHS on CChinduced muscle contraction in freshly dispersed muscle cells by scanning micrometry. As in
muscle strips, contractile agonist induce biphasic contraction in isolated muscle cells: a rapid
contraction within 30 s followed by a sustained contraction for 20 min.143 To examine the effect
of L-cysteine or NaHS on sustained contraction, muscle cells were treated with different
concentrations of CCh (0.1 nM to 10 μM) in the presence or absence of L-cysteine (10 mM) or
NaHS (1 mM) for 10 min. CCh caused a concentration-dependent contraction in dispersed
muscle cells with an EC50 of 12 nM. In the presence of L-cysteine or NaHS the contractile
response to CCh was shifted to the right suggesting inhibition of contraction with EC50 values of
25 nM and 79 nM, respectively (Fig. 4).

Addition of L-cysteine caused inhibition of CCh-

induced contraction (i.e. relaxation) in a concentration-dependent fashion (Fig. 5).

Relaxation

responses were 35±5% at 1 mM L-cysteine (p<0.001), 58±6% at 10 mM L-cysteine (p<0.001),
and 79±8% at 100 mM L-cysteine (p<0.001). Addition of NaHS also caused relaxation in a
concentration-dependent fashion (Fig. 6). Relaxation responses were 50±5 % at 1 mM NaHS
(p<0.001), 65± 7% at 10 mM NaHS (p<0.001), and 83±6% at 100 mM NaHS (p<0.001) (Fig.
6). The effect of 10 mM L-cysteine (39±3% vs 36±4% relaxation ) or 1 mM NaHS (48±5% vs.
47±6% relaxation) on CCh-induced contraction was not affected in the presence of
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glibenclamide (Fig. 7). Control studies showed that relaxation (52±7% relaxation) in response to
levcromakalin, a potassium channel activator was inhibited by glibenclamide (8±4% relaxation).
(Fig 8). The results suggest that both endogenous (via activation of CSE by L-cysteine) and
exogenous H2S inhibit muscle contraction. The results also suggest that the inhibitory effect of
H2S is independent of KATP channel activation.
C4. Mechanism of action of H2S to mediate muscle relaxation
Previous studies have shown that muscle relaxation in response to inhibitory transmitters
such as VIP or NO was mediated by generation of cAMP and cGMP, and activation of cAMPdependent kinase (PKA) and cGMP-dependent protein kinase (PKG), respectively. Selective
inhibitors of PKA (H-89) or PKG (Rp-cGMPS) were used to examine the involvement of PKA
and PKG in L-cysteine- and NaHS-induced relaxation. Relaxation in response to 10 mM Lcysteine (48±5% relaxation) was not affected by 1 μM H-89 (51±6% relaxation) or 1 μM RpcGMPS (42±5% relaxation) (Fig. 9). Similarly, relaxation in response to 1 mM NaHS (59±4%
relaxation) was not affected by 1 μM H-89 (55±5% relaxation) or 1 μM Rp-cGMPS (51±4%
relaxation) (Fig. 9).

Control studies showed that relaxation in response to NO donor, S-

nitrosoglutathione (GSNO, 10 µM) which generates cGMP and activates PKG was inhibited by
Rp-cGMPS, but not by H-89 (61±8% relaxation with GSNO, 12±4% relaxation with GSNO and
Rp-cGMPS, and 52±6% relaxation with GSNO and H-89) (Fig 10). Relaxation in response to
forskolin, which generates cAMP and activates PKA was inhibited by H-89, but not by RpcGMPS (65±4% relaxation with forskolin, 12±4% relaxation with forskolin and H-89, and
58±5% relaxation with forskolin and Rp-cGMPS) (Fig. 10). These results suggest that relaxation
by H2S was independent of PKA and PKG activation.
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C4a. Effect of H2S on cAMP levels in isolated muscle cells from the stomach
Lack of effect of PKA inhibitor on muscle relaxation in response to L-cysteine and NaHS
was corroborated by measurements of cAMP. Muscle cells were treated with L-cysteine (10
mM), NaHS (1 mM) or forskolin (10mM) for 5 min in the presence of IBMX (10 µM) and cAMP
levels are measured by radioimmuno assay.

Treatment of cells with L-cysteine (2.1±0.35

pmol/mg protein) or NaHS (2.6±0.4 pmol/mg protein) did not change the levels of cAMP
compared to basal cAMP levels (1.8±0.25 pmol/mg protein) (Fig. 11). In contrast, forskolin
caused a significant increase (17.6±2.1 pmol/mg protein, p<0.001) in cAMP levels above basal
levels (Fig. 11). These results suggest that H2S does not stimulate adenylyl cyclase activity and
increase the cAMP levels in the gastric muscle cells; but induce relaxation through other
pathways that inhibit contraction.
C4b. Inhibition of Rho kinase activity by H2S.
Previous studies in gastric muscle have shown sustained contraction in response to CCh
is mediated by activation of RhoA/Rho kinase pathways involving phosphorylation of MYPT1,
the regulatory subunit of MLC phosphatase, via Rho kinase leading to inhibition of MLC
phosphatase and increase in MLC20 phosphorylation, a prerequisite for contraction. As shown
previously, sustained contraction (31±3% decrease in cell length) in response to CCh was
inhibited by the selective Rho kinase inhibitor, Y27632 (1 mM) (4±4% decrease in cell length) 140
(Fig. 12). We next examined the hypothesis that inhibition of contraction by H2S is due to
inhibition of Rho kinase leading to activation of MLC phosphatase and MLC20
dephosphorylation, a prerequisite for relaxation.
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As shown previously140, treatment of cells with 0.1 μM CCh for 10 min caused a
significant increase in Rho kinase activity above basal levels (268±12% increase, p<0.001) (Fig.
13). Addition of L-cysteine (10 mM) caused significant inhibition of CCh-stimulated Rho kinase
activity (62±4% inhibition, p<0.001). Similarly, addition of NaHS (1 mM) caused significant
inhibiton of CCh-stimulated Rho kinase activity (76±6% inhibition, p<0.001) (Fig. 13). These
results suggest that relaxation of sustained contraction by H2S was due to inhibition of Rho
kinase activity.
C4c. Inhibition of Rho kinase activity by L-cysteine is mediated via CSE/ H2S
The involvement of endogenous H2S generation in the inhibition of Rho kinase by Lcysteine was examined by transfection of cultured muscle cells with CSE specific siRNA.
Suppression of CSE was verified by western blot (Fig. 14). CCh induced significant increase
(238±15% increase above basal level) in Rho kinase activity in cultured muscle cells. Addition
of L-cysteine (10 mM) caused significant inhibition of CCh-stimulated Rho kinase activity
(85±8% inhibition) in cells transfected with control siRNA but not in cells transfected with CSEspecific siRNA (19±9% inhibition) (Fig. 14). These results provide evidence for the involvement
of CSE, probably via generation of H2S, in the inhibition of Rho kinase activity.
In summary,
1. CSE, but not CBS is expressed in gastric smooth muscle cells.
2.

L-cysteine, an activator of CSE, and H2S donor NaHS caused relaxation of sustained

contraction in a concentration-dependent fashion in muscle strips. Relaxation by L-cysteine and
NaHS was not affected by the KATP channel blocker, glibenclamide.
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3. L-cysteine and NaHS caused relaxation of sustained contraction in a concentration-dependent
fashion in freshly dispersed muscle cells. Relaxation by L-cysteine and NaHS was not affected
by the KATP channel blocker, glibenclamide, PKA inhibitor, H-89 or PKG inhibitor, Rp-cGMPS.
L-cysteine and NaHS had no effect on cAMP levels.
4. L-cysteine and NaHS caused inhibition of CCh-stimulated Rho kinase activity. Previous
studies have shown that sustained contraction by CCh was inhibited by the selective Rho kinase
inhibitor, Y27632 (1 µM).
5. Inhibition of Rho kinase activity by L-cysteine was blocked in cells transfected with CSE
specific siRNA.
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Figure 1. Expression of CSE in smooth muscle cells. (A) CSE expression was identified in
cultured muscle cells from stomach and colon of rabbit, mouse and human by RT-PCR. A PCR
product of the expected size was obtained with CSE specific primers using RNA isolated from
cultured muscle cells derived from stomach and colon of rabbit (560 bp), mouse (851 bp) and
human (312 bp). Under similar conditions, there was no detectable PCR product with CBSspecific primers from cultured muscle cells of stomach and colon of rabbit, mouse and human.
(B) Western blot analysis using specific antibody to CSE (1:1000) demonstrated the presence of
CSE protein (66 kDa) in lysates derived from muscle cells of stomach and colon of rabbit, mouse
and human. Under similar conditions, there was no detectable expression of CBS protein with
the lysates derived from dispersed muscle cells of stomach and colon of rabbit, mouse and
human.
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Figure 1-A- Expression of mRNA

Figure 1-B- CSE protein expression
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Figure 2. Effect of L-cysteine on carbachol-induced contraction in gastric muscle strips.
Muscle strips from rabbit proximal stomach were allowed to equilibrate to a passive tension of
2g for 30 min and then treated with carbachol (CCh, 10 µM). The increase in tension (increase
in the amplitude) in response to CCh was calculated as contraction. After the muscle attained
sustained contraction, different concentrations of L-cysteine was added in the presence or
absence of glibenclamide (10 µM). Inhibition of contraction was calculated as relaxation and
expressed as percent inhibition of maximum tension. Values are means ± SEM of 4 experiments.
** p<0.001 significant inhibition of CCh-induced contraction.
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Figure 2
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Figure 3. Effect of NaHS on carbachol-induced contraction in gastric muscle strips. Muscle
strips from rabbit proximal stomach were allowed to equilibrate to a passive tension of 2g for 30
min and then treated with carbachol (CCh, 10 µM). The increase in tension (increase in the
amplitude) in response to CCh was calculated as contraction.

After the muscle attained

sustained contraction, different concentrations of NaHS was added in the presence or absence of
glibenclamide (10 µM). Inhibition of contraction was calculated as relaxation and expressed as
percent inhibition of maximum tension. Values are means ± SEM of 4 experiments. ** p<0.001
significant inhibition of CCh-induced contraction.
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Figure 3
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Figure 4. Effect of L-cysteine and NaHS on carbachol-induced contraction in isolated
muscle cells of stomach.

Muscle cells isolated from proximal stomach were treated with

different concentrations of CCh (0.1nM to 10 µM) for 10 min. In some experiments cells were
pretreated for 10 min with 10mM L-cysteine or 1mM NaHS and then treated with CCh. Muscle
cell length was measured by scanning micrometry. Contraction by CCh was calculated as
decrease in muscle length from control cell length of 104±5 mm. Values are means ± SEM of 7
experiments.
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Figure 5. Effect of L-cysteine on carbachol-induced contraction in isolated muscle cells of
stomach. Muscle cells isolated from proximal stomach were treated with CCh (0.1 µM) for 10
min to induce sustained contraction. In some experiments cells were pretreated with different
concentrations of L-cysteine for 10 min and then treated with CCh for 10 min. Muscle cell
length was measured by scanning micrometry. Contraction by CCh was calculated as decrease
in muscle length from control cell length (30±3% decrease in cell length from the basal cell
length of 109±5 mm). Relaxation by L-cysteine was expressed as percent decrease in CChinduced contraction.

Values are means ± SEM of 7 experiments. ** p<0.001, significant

inhibition of CCh-induced contraction.
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Figure 5
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Figure 6. Effect of NaHS on carbachol-induced contraction in isolated muscle cells of
stomach. Muscle cells isolated from proximal stomach were treated with CCh (0.1 µM) for 10
min to induce sustained contraction. In some experiments cells were pretreated with different
concentrations of NaHS for 10 min and then treated with CCh for 10 min. Muscle cell length
was measured by scanning micrometry. Contraction by CCh was calculated as decrease in
muscle length from control cell length (30±3% decrease in cell length from the basal cell length
of 109±5 mm). Relaxation by NaHS was expressed as percent decrease in CCh-induced
contraction.

Values are means ± SEM of 7 experiments. ** p<0.001, significant inhibition of

CCh-induced contraction.
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Figure 7. Effect of glibenclamide on relaxation induced by L-cysteine and NaHS in isolated
muscle cells of stomach. Muscle cells isolated from proximal stomach were treated with CCh
(0.1 µM) for 10 min to induce sustained contraction. In some experiments cells were pretreated
with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of glibenclamide (10 µM)
for 10 min and then treated with CCh for 10 min. Muscle cell length was measured by scanning
micrometry. Contraction by CCh was calculated as decrease in muscle length from control cell
length (29±4% decrease in cell length from the basal cell length 104±5 mm). Relaxation in
response to L-cysteine or NaHS was expressed as percent decrease in contraction.

Values are

means ± SEM of 7 experiments. ** p< 0.01, significant inhibition of CCh-induced muscle
contraction.
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Figure 8.

Effect of glibenclamide on relaxation induced by levcromakalin in isolated

muscle cells of stomach. Muscle cells isolated from proximal stomach were treated with CCh
(0.1 µM) for 10 min to induce sustained contraction. In some experiments cells were pretreated
with levcromakalin (10 µM) in the presence or absence of glibenclamide (10 µM) for 10 min and
then treated with CCh for 10 min. Muscle cell length was measured by scanning micrometry.
Contraction by CCh was calculated as decrease in muscle length from control cell length (29±4%
decrease in cell length from the basal cell length 104±5 mm).

Relaxation in response to

levcromakalin was expressed as percent decrease in contraction. Values are means ± SEM of 4
experiments. ** p< 0.001, significant inhibition of CCh-induced muscle contraction.
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Figure 9. Effect of H-89 and Rp-cGMPS on relaxation induced by L-cysteine and NaHS in
isolated muscle cells of stomach. Muscle cells isolated from proximal stomach were treated
with CCh (0.1 µM) for 10 min to induce sustained contraction. In some experiments cells were
pretreated with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of PKA
inhibitor, H-89 (1 µM) or PKG inhibitor, Rp, cGMPS (1 µM) for 10 min and then treated with
CCh for 10 min. Muscle cell length was measured by scanning micrometry. Contraction by
CCh was calculated as decrease in muscle length from control cell length (29±4% decrease in
cell length from the basal cell length 104±5 mm). Relaxation in response to L-cysteine or NaHS
was expressed as percent decrease in contraction. Values are means ± SEM of 7 experiments.
** p< 0.001, significant inhibition of CCh-induced muscle contraction.
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Figure 10. Effect of H-89 and Rp-cGMPS on relaxation induced by forskolin and Snitrosoglutathione, respectively, in isolated muscle cells of stomach. Muscle cells isolated
from proximal stomach were treated with CCh (0.1 µM) for 10 min to induce sustained
contraction. In some experiments cells were pretreated with GSNO (10 µM) in the presence or
absence of Rp-cGMPS (1 µM) or forskolin (10 µM) in the presence or absence of H-89 (1 µM)
for 10 min and then treated with CCh for 10 min. Muscle cell length was measured by scanning
micrometry. Contraction by CCh was calculated as decrease in muscle length from control cell
length (29±4% decrease in cell length from the basal cell length 104±5 mm). Relaxation in
response to GSNO or forskolin was expressed as percent decrease in contraction.

Values are

means ± SEM of 4 experiments. ** p< 0.001, significant inhibition of CCh-induced muscle
contraction.
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Figure 10
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Figure 11: Effect of L-cysteine and NaHS on adenylyl cyclase activity in isolated muscle
cells of stomach. Muscle cells isolated from proximal stomach were treated with NaHS (1 mM)
and L-Cysteine (10 mM), or forskolin (10 µM) for 5 min. Stimulation of adenylyl cyclase
activity was measured as increase in cAMP levels above basal levels cAMP levels were
measures by radioimmunoassay. Results are expressed as pmol/mg protein. ** p<0.001
significant increase in cAMP levels.
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Figure 12. Effect of Rho kinase inhibitor in CCh-induced sustained contraction. Muscle
cells isolated from proximal stomach were treated with CCh (0.1 µM) in the presence or absence
of the Rho kinase inhibitor Y27632 (1 µM) for 10 min to induce sustained contraction. Muscle
cell length was measured by scanning micrometry. Contraction by CCh was calculated as
decrease in muscle length from control cell length (31±3% decrease in cell length from the basal
cell length 101±6 mm). Values are means ± SEM of 4 experiments. ** p< 0.01, significant
inhibition of CCh-induced muscle contraction.
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Figure 12
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Figure 13. Effect of L-cysteine and NaHS on carbachol-stimulated Rho kinase activity in
isolated muscle cells of stomach. Muscle cells isolated from proximal stomach were treated
with CCh for 10 min. In some experiments cells were pretreated with L-cysteine (10 mM) or
NaHS (1 mM) for 10 min and then treated with CCh for 10 min. Rho kinase activity was
measured by immunokinase assay using [32P]ATP. Results are expressed as cpm/mg protein.
Values are means ±SEM of 4-6 experiments. **p<0.001 significant inhibition of CCh-stimulated
Rho kinase activity.
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Figure 14. Effect of CSE siRNA on L-cysteine-induced inhibition of Rho kinase activity.
Cultured gastric muscle cells were transfected with control siRNA or CSE-specific siRNA for 48
h. Expression of CSE was measured by western blot (inset). Cells were treated with CCh (0.1
µM) for 10 min In some experiments the transfected cells were pretreated for 10 min with Lcysteine (10 mM) and then treated with CCh for 10 min. Rho kinase activity was measured by
immunokinase assay using [32P]ATP. Results are expressed as cpm/mg protein. Values are
means±SEM of 4-6 experiments. **p< 0.001, significant inhibition of CCh-stimulated Rho
kinase activity by L-cysteine.
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Figure 14
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D. DISCUSSION
Though the existence of H2S in biological tissues has been known for over 300 years, it is
the most recently appreciated of the gasotransmitters as a physiologic messenger molecule.
Regarded as a third gasotransmitter, H2S is receiving increasing interest, as much as NO and CO
has received previously, to understand its physiological functions. 142 Using exogenous H2S
donors or activators of endogenous enzymes such as CSE and CBS that generate H2S, CSE
siRNA and CSE-/- mice, regulation of several functions by H2S has been demonstrated and these
include cardiovascular, gastrointestinal and central nervous system, and energy metabolism.
Inhibitors of these enzymes have been employed to characterize influences of H2S in various
organs in mammals. Definitive evidence that H2S is a physiologic regulator came with the
knockout mice with targeted deletion of CSE and CBS.
In the gastrointestinal (GI) tract, H2S synthesizing enzymes are expressed by enteric
neurons, interstitial cells of Cajal and in the epithelium. 143 In addition, the gut microbiota
produces H2S which leads to luminal concentrations of H2S of up to 1 mM.144 Transcripts
encoding both CSE and CBS have been identified in different cell types in the GI system. H2S is
produced by activation of these enzymes but no evidence indicates the physiological mechanisms
of activation of the H2S synthesizing enzymes. Recently, several studies reported actions of H2S
on various GI functions. These functions include inflammatory and anti-inflammatory,
nociceptive and anti-nociceptive actions, and regulation of gastric mucosal blood flow, secretion
and GI motility. 145 146 Currently, the most advanced efforts to develop therapeutic agents involve
the combination of H2S donors with non-steroidal anti-inflammatory drugs (NSAIDs). The H2S
releasing moiety provides cytoprotection to gastric mucosa normally adversely affected by
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NSAIDs while the combination of H2S and inhibition of prostaglandin synthesis may afford
synergistic anti-inflammatory influences.
The important findings of our study are summarized as follows: i) transcripts of the H2Ssynthesizing enzymes CSE, but not CBS have been detected in isolated muscle cells, where it is
responsible for H2S production; ii) endogenous activation of CSE by L-cysteine inhibited
agonist-induced Rho kinase activity and muscle contraction; iii) suppression of CSE expression
blocked the effect of L-cysteine on Rho kinase activity providing strong evidence that H2S may
be responsible for L-cysteine-induced inhibitory effects;

iv) exogenous H2S donor, NaHS

inhibited agonist-induced Rho kinase activity and muscle contraction, v) the effect of L-cysteine
and NaHS was not affected by blockade of KATP channel with glibenclamide, PKA with H-89 or
PKG with Rp-cGMP. These studies suggest that a distinct PKA/PKG-independent mechanism
via inhibition of Rho kinase activity mediates muscle relaxation by H2S.
Recent studies in vascular and visceral smooth muscle have clearly established the H2S as
a mediator of relaxation. Expression of CSE is down regulated in hypertensive animal models.
CSE-/- mice are hypertensive and exhibit reduced endothelium-dependent vasorelaxation; these
effects are associated with decrease in H2S generation in these mice.

Exogenous H2S

administration reduced blood pressure, whereas inhibition of CSE activity with DLpropargylglycine increased blood pressure in rats.147 Extensive experiments on vascular tissues
strongly suggest that H2S-induced vasorelaxation is mainly caused by KATP channel openings.
This notion is largely based on the ability of glibenclamide, a KATP channel antagonist, to block
the vasorelaxant effects of H2S.148 Systemic administration of different H2S donors inhibits
visceral nociception by opening KATP channels. The activation of KATP channels in the peripheral
nociceptive system has been seen to be involved in the modulation of nociception.
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Additional

targets such as voltage-dependent Ca2+ channels, Ca2+-dependent K+ channels and ill-defined
endothelium-dependent mechanisms appear to play a minor role in H2S induced vasodilation.
Generalization of these inhibitory mechanisms to other smooth muscle is problematic. The
mechanism of inhibition of contraction by H2S appears to be species- and tissue-specific, and
varies with activation of the muscle. Inhibition of contraction by NaHS in urinary bladder was
abolished by capsaicin suggesting the involvement of TRPV1 receptors.

Glibenclamide

insensitive effect of NaHS was also observed in mouse aorta, mouse bronchial rings, and mouse
gastric fundus and guinea pig ileum. 149

150

However, inhibition of spontaneous contractions by

NaHS in human and rat colon were affected by glibenclamide and apamin. In these nervemuscle preparation, H2S may also affect enteric neurons to regulate smooth muscle function. A
direct effect on muscle was implicated in distal colon of mouse and human since the Na+ channel
blocker tetradotoxin had no effect on the relaxation. However, an effect on interstitial cells of
Cajal would also influence the function of smooth muscle in these preparations.
Although, exogenous NaHS has potent inhibitory effect on muscle contraction both in
muscle strip preparations and isolated muscle cells, it was demonstrated that luminal application
of NaHS was less effective than in isolated strips.151 This could be due to effective barrier
function of mucosa to limit the diffusion of H2S to the muscle layers and efficient metabolism of
H2S to thiosulfate and sulphate by colonic mucosa. In humans and mice, H2S can be produced
upto 1mM range in the GI tract and efficient oxidation process by sulphide quinine
oxidoreductase, sulphur dioxygenase and rhodanese would offer protection against high local
concentrations.152 Damage to this protective mucosal barrier function, as in the ulcerative colitis,
may lead to increased access of H2S to the inner muscle layers of GI tract.
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Use of innervated muscle strips, isolated muscle strips limits the interpretation about the
precise site of H2S synthesis and its action. In the present study, using dispersed muscle cells and
using activator of CSE and H2S donor, we showed that H2S inhibits CCh-induced sustained
contraction. Evidence for the activation of CSE in mediating the effect of L-cysteine was based
on selective expression of CSE in muscle cells. These results also strongly suggest that
endogenous H2S may be responsible for the L-cysteine–induced relaxation seen in our
experiments. We carried out further experiments in dispersed muscle cells to investigate the
mechanism of action of H2S to mediate relaxation of sustained contraction.

Our studies

demonstrated that the inhibition of contraction is mediated via inhibition of CCh-induced Rho
kinase activity. Evidence for this conclusion was based on inhibition of CCh-induce Rho kinase
activity by both endogenous and exogenous H2 S and blockade of sustained contraction by
Y27632, a selective Rho kinase inhibitor. Further evidence was provided using CSE siRNA.
Suppression of CSE expression blocked the inhibitory effect of L-cysteine on Rho kinase
activity. Glibenclamide, a selective inhibitor of KATP channels and a well-characterized target of
H2S to mediate muscle relaxation, had no effect on inhibition of contraction by L-cysteine or
NaHS.
Previous studies have demonstrated that relaxation of RhoA/Rho kinase-mediated
contraction by PKA and PKG involves phosphorylation of RhoA at Ser188 and inhibition of its
ability to activate Rho kinase, phosphorylation of MYPT1 at Ser695 and blockade of inhibitory
phosphorylation at the adjacent Thr696 by Rho kinase, and/or phosphorylation of telokin at Ser13,
an endogenous MLC phosphatase stimulator.153

154

We examined whether H2S mediated

inhibition of Rho kinase activity and contraction involves cAMP- and/or cGMP-dependent
mechanisms. Studies also showed that L-cysteine or NaHS had no effect on cAMP levels and
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the effect of H2S on contraction was not affected in the presence of PKA or PKG inhibitors.
Similarly, inhibition of contraction by NaHS in mouse distal colon strips was not affected by NO
synthase inhibitor, L-NAME, sGC inhibitor, ODQ, or SQ22536, adenylyl cyclise inhibitor
observed in mouse distal colon strips. 155 These results suggest that the relaxation by H2S was
mediated via a distinct mechanism independent of cAMP/PKA and cGMP/PKG pathways. H2S
act via protein sulfhydration to regulate various physiological functions. Future studies involve
measurement of S-sulfhydration of Rho kinase or upstream targets such RhoA in response to Lcysteine or NaHS. S-sulfhydration provides a possible mechanism by which H2S alters the
function of several proteins and this process appears to common posttranslational modification
and analogous to S-nitrosylation of proteins by NO. In this process, a hydropersulfide (-SSH)
moiety is generated by the addition of sulphur from H2S to the –SH groups of cysteine residues
and this results in altered chemical and biological reactivity of proteins. Snyder and colleagues
have shown loss of protein sulfhydration in CSE-/- mice compared to proteins in control mice.156
The covalent modification of proteins by sulfhydration is a well characterized mechanism, but
the physiological mechanism in the reversal of sulfhydration is not clear. Sulfhydration is
reversed by reducing agents such as dithiothreitol.
In summary, our studies have demonstrated that both exogenous and endogenous H2S
inhibits agonist-induced sustained muscle contraction in the stomach, and the inhibitory effect is
mediated via inhibition of Rho kinase activity, a key enzyme in the regulation of MLC
phosphatase activity and sustained muscle contraction. Inhibition of Rho kinase activity and
ensuing disinhibition of MLC phosphatase activity leads to MLC20 dephosphorylation, a
prerequisite for muscle relaxation (Fig 15). The extent to which endogenous H2S contributes to
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smooth muscle tone and gastrointestinal motility under physiological conditions, and the
physiological mechanism that regulate CSE activity and H2S generation awaits further research.

74

Figure 15: Scheme depicting the pathways involved in the regulation of MLC20
phosphorylation and muscle contraction in smooth muscle. MLC20 Phosphorylation in
response to contractile agonists is initiated by stimulation of Ca2+ calmodulin-dependent MLC
kinase and sustained by inhibition of MLC phosphatase activity via Rho kinase-dependent
phosphorylation of MLC phosphatase regulatory subunit. H2S inhibits Rho kinase activity
leading to stimulation of MLC phosphatase activity, MLC20 dephosphorylation and muscle
relaxation.
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Figure 15
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